Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Operating Margin Over TimeContracting
Percentile Rank7
3Y CAGR-17.4%
5Y CAGR-9.9%
Year-over-Year Change
Operating income as a percentage of revenue
3Y CAGR
-17.4%/yr
vs +4.0%/yr prior
5Y CAGR
-9.9%/yr
Recent deceleration
Acceleration
-21.4pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.6x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 24.95% | -11.2% |
| 2024 | 28.10% | -15.2% |
| 2023 | 33.15% | -25.1% |
| 2022 | 44.24% | -20.5% |
| 2021 | 55.67% | +32.3% |
| 2020 | 42.09% | +24.9% |
| 2019 | 33.70% | -10.8% |
| 2018 | 37.77% | +6.6% |
| 2017 | 35.41% | +29.3% |
| 2016 | 27.38% | - |